B Vural, F Atalar, C Ciftci, A Demirkan, B Susleyici- … - Cardiovascular …, 2008 - Elsevier Metabolic syndrome is a cluster of different clinical manifestations that are risk factors for atherothrombotic
cardiovascular disorders. Fatty-acid-binding protein 4 (FABP4/aP2), which is highly expressed
in adipocytes, specifically exerts intracellular lipid trafficking. A high level of fatty-acid- ... Cited by 7 - Related articles - All 17 versions
H Koh… - Diabetes care, 2009 - Am Diabetes Assoc RESULTS—A-FABP levels, defined as more than a moderate degree of fatty liver compared
with men, those without metabolic syndrome, and those without NAFLD, were higher in
women, patients with metabolic syndrome, and patients with overt NAFLD, respectively. ... Cited by 2 - Related articles - All 4 versions
RLC Hoo, DCY Yeung, KSL Lam, A Xu - Expert Review of …, 2008 - ingentaconnect.com Obesity is an important risk factor for a cluster of metabolic and cardiovascular diseases, including
insulin resistance, Type 2 diabetes, nonalcoholic fatty liver disease and atherosclerosis. Systemic
low-grade inflammation, characterized by elevated circulating concentrations of ... Cited by 2 - Related articles - BL Direct - All 3 versions
- ►nursing2008.com [PDF] KM Choi, TN Kim, HJ Yoo, KW Lee, GJ Cho, TG … - Clinical …, 2009 - pt.wkhealth.com Results: Obese women exhibited higher A-FABP levels compared to nonobese women (21·4
± 6·4 µg/l vs. 13·6 ± 4·4 µg/l, P < 0·001). However, neither lipocalin-2 nor RBP4 levels were significantly
different between the two groups, although the difference in lipocalin-2 was marginally ... Cited by 2 - Related articles - All 5 versions
- ►oxfordjournals.org DCY Yeung, Y Wang, A Xu, SCW Cheung, N … - European Heart …, 2008 - Eur Soc Cardiology Methods and results: The presence of E-FABP in human plasma was detected by tandem mass
spectrometry. Serum E-FABP levels, determined by an enzyme-linked immunosorbent assay
in 479 Chinese subjects (age: 55.4 ± 13.5 years; M/F: 232/247), correlated positively (P < ... Cited by 1 - Related articles - All 3 versions
E Krušinová, T Pelikánová - Diabetes Research and Clinical Practice, 2008 - Elsevier Adipocyte/macrophage fatty acid binding protein (A-FABP) has been shown to be closely associated
with metabolic syndrome, obesity and development of atherosclerosis. Moreover, A-FABP has
been recently suggested as a potential therapeutic target of these abnormalities in animal ... Cited by 1 - Related articles - All 10 versions
WY So, PC Tong, GT Ko, RC Ma, R Ozaki, AP Kong … - Diabetes Research and …, 2009 - Elsevier Adiponectin is an adipocytokine with insulin sensitizing effect while chronic inflammation damages
pancreatic β-cells leading to reduced insulin response. We aimed to prove the hypothesis that
adiponectin levels and inflammatory markers (white blood cell counts [WCC], ... Related articles - All 4 versions
DCY Yeung, KSL Lam, Y Wang, AWK Tso, A … - Journal of Clinical …, 2009 - Endocrine Soc Results: Serum ZAG levels were higher in men (P < 0.001 vs. women). Serum ZAG correlated
positively with age, parameters of adiposity (waist circumference and BMI), fasting insulin, insulin
resistance indices, serum triglycerides, adipocyte-fatty acid-binding protein, and ... Related articles - All 3 versions
- ►nursing2008.com G Sommer, M Ziegelmeier, A Bachmann, S … - Clinical …, 2008 - pt.wkhealth.com Objective: Adipocyte fatty acid-binding protein (AFABP) was recently introduced as an
adipocyte-expressed factor, serum levels of which independently correlate with the development
of the metabolic syndrome and cardiovascular disease in humans. In the current study, ... Related articles - All 7 versions
